0.05Open0.05Pre Close0 Volume1.40K Open Interest90.00Strike Price0.00Turnover48.45%IV30.72%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier23DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.0172Delta0.0051Gamma1377.80Leverage Ratio-0.0076Theta0.0007Rho23.73Eff Leverage0.0074Vega
A.O. Smith Stock Discussion
Meanwhile, 40 names in the S&P 500 also hit fresh 52-week highs, including $Amazon (AMZN.US)$ , $Loews (L.US)$ and ...
Gap Ups
1. $Oak Street Health (OSH.US)$ - down 24.4%
2. $Tata Motors (TTM.US)$ - down 2.6%
3. $Vale SA (VALE.US)$ - up 0.6%
4. $Warner Bros Discovery (WBD.US)$ - up 0.5%
5. $argenx SE (ARGX.US)$ - up 0.3%
Gap Downs
1. $Omega Healthcare Investors Inc (OHI.US)$ - down 2.4%
2. $Illumina (ILMN.US)$ - down 2....
In reaction to earnings/guidance:
• $Constellation Energy (CEG.US)$ +8.2%, $Walgreens Boots Alliance (WBA.US)$ +6.8%, $QuidelOrtho (QDEL.US)$ +6.7% (guides Q3 revs well above consensus), $Domino's Pizza (DPZ.US)$ +5.9%, $Delta Air Lines (DAL.US)$ +4.2%, $Commercial Metals (CMC.US)$ +3.5%, $Victoria's Secret (VSCO.US)$ +3.3%, $Taiwan Semiconductor (TSM.US)$ +2.6%
Other news:
• $Axsome Therapeutics (AXSM.US)$ +12.2% (trading h...
• $Theravance Biopharma (TBPH.US)$ +15.9% (TBPH to sell all of its units in Theravance Respiratory to RPRX for over $1.5 bln)
• $Amryt Pharma (AMYT.US)$ +11.9% (FDA grants Orphan Drug Designation to Mycapssa for the treatment of Carcinoid Syndrome)
• $Green Brick Partners (GRBK.US)$ +7.3% (to join S&P SmallCap 600)
• $TransGlobe Energy (TGA.US)$ +6.9% (Transglobe Energy to be acquired by VALLCO Energy (EGY) in stock-for-stock...
• $Advanced Micro Devices (AMD.US)$: BMO Capital Upgrades to Outperform from Market Perform - PT $115 (from $100)
• $Amphenol (APH.US)$ : JPMorgan Upgrades to Overweight from Neutral - PT $83
• $CDW Corp (CDW.US)$ : JPMorgan Upgrades to Overweight from Neutral - PT $200 (from $205)
• $Costco (COST.US)$: Deutsche Bank Upgrades to Buy from Hold - PT $579 (from $525)
• $New Oriental (EDU.US)$ : CICC Upgrades to Outperform from M...
• $Resolute Forest Products (RFP.US)$ +65.7% (entered into an agreement under which Domtar will acquire all of the outstanding common shares of Resolute stock for $20.50 per share and one Contingent Value Right)
• $Applied Molecular (AMTI.US)$ +2.9% (to report top-line Phase 2 results from MARKET combination Trial of Oral AMT-101)
• $Primoris Services (PRIM.US)$ +2.1% (awarded a $170 mln project by Texas DOT)
• $Biogen (BIIB.US)$ +2.1% (Bi...
• $A.O. Smith (AOS.US)$ : Longbow Research Upgrades to Buy from Neutral - PT $71
• $Callon Petroleum (CPE.US)$ : RBC Upgrades to Outperform from Sector Perform - PT $75
• $Dun & Bradstreet (DNB.US)$ : BofA Securities Upgrades to Neutral from Underperform - PT $17 (from $16)
• $Enanta Pharmaceuticals (ENTA.US)$ : Evercore ISI Upgrades to Outperform from In Line - PT $62 (from $39)
• $Corning (GLW.US)$ : CFRA Upgrades to Strong Buy ...
No comment yet